Top Articles

The celebrations of the Dystonia Europe 25th annniversary kicked off with a special lunch event in the European Parliament on 12 April. The 65 guests were welcomed by the Finnish Member of the European Parliament (MEP) Ms. Merja Kyllönen.  She… Continue Reading

  The democratic body of the European Academy of Neurology (EAN) is the assembly of delegates, which acts as the parliament of the EAN. This assembly meets once a year, usually on Saturday, during the annual meeting. The 4 major… Continue Reading

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!   Rolf Fronczek, MD, PhD
Dept. of… Continue Reading

  Portugal has a long tradition in the study of behavioral disorders, dating back to the work of Egas Moniz and his attempt to improve some psychosis with psychosurgery. In the early 1970’s Antonio Damasio, who was taking his PhD… Continue Reading

For May 2018, we have selected: Kappos L, Bar-Or A, Cree BAC, et al., for the EXPAND Clinical Investigators. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomized, phase 3 study. Lancet Neurol 2018;391:1263-1273. Secondary progressive multiple sclerosis (SPMS) is characterized by a previous history of relapsing remitting MS (RRMS) and the continuous progression of disability over the years typically without relapses.

Portugal is a country with a 900-year history: many remnants of past colonization by Celtics, Romans, and Arabians are still present. Unquestionably, the greater contribution of Portugal to the humanity have been the overseas navigations around the world, namely the discovery of the maritime way to India, the discovery of Brazil and of several Atlantic islands.

TEST YOURSELF ACROSS THE NEUROLOGY CURRICULUM – ENTIRELY FREE FOR EAN MEMBERS Whether you are a trainee preparing for your exit exam, or a specialist looking for objective feedback on your knowledge, this online self-assessment exercise will be open from… Continue Reading

Prof. Wolfgang Oertel (WO): Dear Prof. Di Luca I congratulate you with your new position and kindly ask you to illustrate your plans for EBC’s strategy and work in the years to come. Prof. Monica Di Luca (MDL): Being elected as President of EBC is a great honour for me as well as an important challenge. This is an important era for EBC. Thanks to the excellent work of the past President David Nutt, the last 4 years witnessed the consolidation of our Council in the European scenario as the ideal platform where all voices related to brain research could find an interlocutor and could merge. We are now in the privileged position to start new projects and bring EBC to a next step.

History Machado-Joseph disease (MJD) is an autosomal dominant (AD) spinocerebellar ataxia (SCA) initially described in descendants of immigrants from the Portuguese islands of the Azores. It was in 1972 that Kenneth K. Nakano and colleagues described the Machado family, with an AD, late onset, cerebellar ataxia with peripheral neuropathy. All family members were descendants from Guilherme Machado, who had migrated from São Miguel (Azores) to Massachusetts in the late nineteenth or early twentieth centuries.

Slovakia, officially the Slovak Republic, is a country in Central Europe. The total area of the Slovak territory is 49 036 km2 and is mostly mountainous. The population is over 5 million. The capital and largest city is Bratislava. However, the Slovak Republic is a young state (established on January 1st, 1993, by the split of Czechoslovakia), indeed it is an old country with rich historical heritage.

THE EUROPEAN ACADEMY OF NEUROLOGY PRESENTS ‘CHALLENGING THE GLOBAL BURDEN OF BRAIN DISEASE’, A COLLABORATION WITH ITN PRODUCTIONS In a unique communications partnership, European Academy of Neurology (EAN) and ITN Productions are producing a news and current affairs-style programme highlighting… Continue Reading

This Brain Awareness Week EFNA are launching a Survey of Young Europeans with Neurological Conditions.

On 12-14 April the Dystonia Europe 25th Anniversary Conference and D-DAYs 2018 will take place in Brussels, Belgium. The 3-day event will include a special lunch in the EU Parliament.